Delivery Order SPE2DB20D3103-SPE2DB23FP6K2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,103.68 for the supply of 4,558,237,997 units of XEOMIN 200 unit vials. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,850.00 firm-fixed-price delivery order is for the supply of XEOMIN 50 unit vials. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $8,550.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564795627 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XEOMIN 100 unit vials. The $10,484.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XEOMIN 200 unit vials to the U.S. government. The contract, valued at $10,485.00, was awarded on June 25, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major DoD agency responsible for providing medical supplies to the U.S. Armed Forces. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
- This federal contract award, valued at $1,572.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of XEOMIN 100 unit vials, a pharmaceutical product, to the U.S. government. The $5,242.40 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $7,379.90 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has no set-aside designation and was awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of XEOMIN 200 unit vials. The single-award Indefinite Delivery Contract (IDC) is valued at up to $12,582.00 and has a completion date of May 10, 2024. This contract is part of a larger $999,999,999.00 IDC that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP6K2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $22,018.08 for the supply of XEOMIN 100 unit vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through September 27, 2023. The contract is a Firm Fixed Price type and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs serve as the primary vehicles for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 9/6/23 |